Hepatitis B News and Research

Latest Hepatitis B News and Research

Generic drug delays cost U.S. payers millions

Problems surrounding an Indian company's launch of generic versions of three blockbuster drugs have preserved millions in revenue for the brand-name makers, reports The Wall Street Journal.

19 Jun 2014

First Edition: June 18, 2014

Today's headlines include a report that the cost of health law subsidies may push the measure's overall price tag beyond projections.

18 Jun 2014

Type I interferons can block development of allergy- and asthma-driving Th2 cells

A mechanism that could underlie the development of cells that drive asthma and allergies has been uncovered by immunology researchers at UT-Southwestern Medical Center.

17 Jun 2014

Arrowhead Research joins with broad-market Russell 3000 Index

Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, is set to join the broad-market Russell 3000 Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 27, according to a preliminary list of additions posted June 13 on www.russell.com/indexes.

16 Jun 2014

States, insurance plans wrestle over decisions to offer costly hepatitis C drug

The medication, named Sovaldi, has shown great promise in fighting the deadly disease, but it is very expensive: The treatment regimen runs about $84,000 per patient.

16 Jun 2014

Poll: Fixing vets' health care high priority

Elsewhere, a senator defends his vote against legislation to try to improve the VA's health care, and The Associated Press looks at doctor's appointment wait times for all Americans.

16 Jun 2014

First Edition: June 13, 2014

Today's headlines include various updates on what Virginia lawmakers did in an attempt to resolve the state's budget impasse and Medicaid expansion debate.

13 Jun 2014

Co-ops struggle to enroll people

Elsewhere, Oregon officials are planning on limiting access to a new, pricey hepatitis C drug to state health plan members. Also, UnitedHealthcare is considering entering Georgia's health care exchange next year.

13 Jun 2014

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT®) and ViiV's Integrase Inhibitor dolutegravir(marketed as TIVICAY®) as the sole active ingredients for the maintenance treatment of people living with Human Immunodeficiency Virus (HIV).

12 Jun 2014

Health tips for global travellers

Nothing ruins a summer vacation faster than getting sick. "Remember that most diseases are transmitted by food, water and insects," says John A. Sellick, Jr., DO, University at Buffalo associate professor of medicine and hospital epidemiologist at Veterans Affairs Western New York Healthcare System. "So get vaccinated, keep insects off you as much as possible and be careful with what you put in your mouth."

11 Jun 2014

AHF welcomes passage of new HIV transmission bill

Marking the first change in state health code regarding HIV transmission in nearly a decade, Iowa Governor Terry E. Branstad signed a landmark bill on May 30 that will curb rampant convictions of people living with HIV for transmitting the virus by redefining the law to ensure only those who intend to spread HIV or behave with "reckless disregard" are penalized.

11 Jun 2014

State highlights: Mass. near 0 percent uninsured; Ga. scraps Medicaid contract bidding; states turn to public health issues

When Massachusetts passed its landmark health coverage law under Gov. Mitt Romney in 2006, no one claimed the state would get to zero, as in 0 percent of residents who are uninsured. But numbers out today suggest Massachusetts is very close. Between December 2013 and March of this year, when the federal government was urging people to enroll, the number of Massachusetts residents signed up for health coverage increased by more than 215,000. If that number holds, the percentage of Massachusetts residents who do not have coverage has dropped to less than 1 percent (Bebinger, 6/9).

11 Jun 2014

Alnylam announces new pre-clinical results with DC for ALN-CC5 to treat complement-mediated diseases

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today new pre-clinical results with its Development Candidate (DC) for ALN-CC5, a subcutaneously administered investigational RNAi therapeutic targeting complement component C5 in development for the treatment of complement-mediated diseases.

10 Jun 2014

Antiviral therapy may prevent hepatitis B virus from developing into hepatocellular carcinoma

Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).

9 Jun 2014

Merck enters into definitive agreement with Idenix

Merck, known as MSD outside the United States and Canada, and Idenix Pharmaceuticals, Inc., today announced that the companies have entered into a definitive agreement under which Merck will acquire Idenix for $24.50 per share in cash.

9 Jun 2014

Viewpoints: Tea party missing the lesson; health care not an ordinary market; Va.'s Medicaid battle

But the Tea Party does have something to show for its five years of annoyance: Ted Cruz, senator from Texas. Cruz is probably best known for reading "Green Eggs and Ham" on the floor of the Senate during a 21-hour talkathon designed to ensure his place as the most hated man in that august chamber.

9 Jun 2014

Studies confirm importance of men seeing physician on regular basis

For many men being a father is about staying strong as they protect and care for their family. Some men see going to the doctor as a weakness or nuisance, but protecting your health is one of the best things a father can do for his family.

6 Jun 2014

U.S. Preventive Services Task Force recommends hepatitis B screening for high risk individuals

A simple blood test can detect if a person is one of the two billion people worldwide infected with hepatitis B. And now the U.S. Preventive Services Task Force recommends that all teens and adults who are high risk for hepatitis B get screened for the infection.

6 Jun 2014

Regeneration of a chronically diseased liver may be possible, say Harvard researchers

Harvard Stem Cell Institute scientists at Boston Children's Hospital have new evidence in mice that it may be possible to repair a chronically diseased liver by forcing mature liver cells to revert back to a stem cell-like state.

6 Jun 2014

State highlights: NYC soda fight back in court; doc training slots in N.Y.; Texas inmate dialysis costs

New York City's battle over sugary drinks is entering its endgame. But much more than soda is at stake. A plan to limit the sale of large, high-calorie beverages, championed by former Mayor Michael R. Bloomberg as a novel way to fight obesity, went before the State Court of Appeals here on Wednesday, the city's final recourse after a lower court judge struck down the proposal last year (Grynbaum, 6/4).

6 Jun 2014

Hepatitis B News and Research

Latest Hepatitis B News and Research

Generic drug delays cost U.S. payers millions

First Edition: June 18, 2014

Type I interferons can block development of allergy- and asthma-driving Th2 cells

Arrowhead Research joins with broad-market Russell 3000 Index

States, insurance plans wrestle over decisions to offer costly hepatitis C drug

Poll: Fixing vets' health care high priority

First Edition: June 13, 2014

Co-ops struggle to enroll people

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Health tips for global travellers

AHF welcomes passage of new HIV transmission bill

State highlights: Mass. near 0 percent uninsured; Ga. scraps Medicaid contract bidding; states turn to public health issues

Alnylam announces new pre-clinical results with DC for ALN-CC5 to treat complement-mediated diseases

Antiviral therapy may prevent hepatitis B virus from developing into hepatocellular carcinoma

Merck enters into definitive agreement with Idenix

Viewpoints: Tea party missing the lesson; health care not an ordinary market; Va.'s Medicaid battle

Studies confirm importance of men seeing physician on regular basis

U.S. Preventive Services Task Force recommends hepatitis B screening for high risk individuals

Regeneration of a chronically diseased liver may be possible, say Harvard researchers

State highlights: NYC soda fight back in court; doc training slots in N.Y.; Texas inmate dialysis costs

Mastering RNA extraction for plant and fungal research – eBook eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Hepatitis B News and Research

Latest Hepatitis B News and Research

Mastering RNA extraction for plant and fungal research – eBook eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in